Clinical trials
Phase 3 Ischemic Attack, Transient trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 3 |
| AstraZeneca | 2 |
| Boston Scientific Corporation | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| Stanford University | 1 |
| University of California, San Francisco | 1 |
| University of North Carolina, Chapel Hill | 1 |
| University of South Florida | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Attack, Transient | 11 |
| Stroke | 9 |
| Atrial Fibrillation | 2 |
| Cerebral Infarction | 2 |
| Ischemic Stroke | 2 |
| Thromboembolism | 2 |
| Atherosclerosis | 1 |
| Carotid Stenosis | 1 |
| Cataplexy | 1 |
| Cerebrovascular Disorders | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.